LOGIN
Aspirin or Rivaroxaban for Preventing Venous Thromboembolism after Total Knee Arthroplasty
December 2022
Aspirin or Rivaroxaban for Preventing Venous Thromboembolism after Total Knee Arthroplasty
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Aspirin versus Rivaroxaban to Prevent Venous Thromboembolism after Total Knee Arthroplasty: A Double-blinded, Randomized Controlled Trial
Rev Bras Ortop (Sao Paulo) . 2021 Oct 25;57(5):741-746Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
Forty patients undergoing total knee arthroplasty for primary knee osteoarthritis were randomized to receive either rivaroxaban (n=20) or Aspirin (acetylsalicylic acid; n=20). Outcomes of interest were hematocrit levels, deep vein thrombosis, and adverse events. Hematocrit levels at 6 and 24 hours, and 2 weeks were similar between the two groups. The incidence of blood transfusion, bleeding, wound...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Join the Conversation
Please Login or Join to leave comments.